EGFR and lung carcinoma: Mao et al. pointed out that circ CDR1-AS was highly expressed in lung cancer and promoted pemetrexed and CDDP chemotherapy resistance by regulating the EGFR/PI3K signaling pathway (Mao and Xu, 2020).